Briefing

Nurosene the latest Canadian healthtech to go public

article-aa

The Toronto-based firm listed on the Canadian Securities Exchange under the ticker symbol MEND at $0.90 a share Wednesday. Its debut follows an oversubscribed initial public offering, through which it raised about $9.2 million, up from its target of between $5 million to $8 million. Canaccord Genuity and Beacon Securities acted as agents in the IPO. (The Logic)

Purchase a subscription to read the full article.

By entering your e-mail you consent to receiving commercial electronic messages from The Logic Inc. containing news, updates, offers or promotions about The Logic Inc.’s products and services. You can withdraw your consent at anytime. Please refer to our privacy policy or contact us for more details.

Already a subscriber?